Home Newsletters Cancer Stem Cell News CHK1 Inhibitor Sensitizes Resistant Colorectal Cancer Stem Cells to Nortopsentin

CHK1 Inhibitor Sensitizes Resistant Colorectal Cancer Stem Cells to Nortopsentin

0
Scientists reported that exposure to a neo-synthetic bis(indolyl)thiazole alkaloid analogue, Nortopsentin 234, led to an initial reduction of proliferative and clonogenic potential of colorectal cancer sphere cells (CR-CSphCs), followed by an adaptive response selecting the CR-CSphCs resistant compartment.
[iScience]

Sorry, but the selected Zotpress account can't be found.

Full ArticleGraphical Abstract
Exit mobile version